HU199428B - Process for producing oxazolidine and imidazolidine compounds - Google Patents

Process for producing oxazolidine and imidazolidine compounds Download PDF

Info

Publication number
HU199428B
HU199428B HU87225A HU22587A HU199428B HU 199428 B HU199428 B HU 199428B HU 87225 A HU87225 A HU 87225A HU 22587 A HU22587 A HU 22587A HU 199428 B HU199428 B HU 199428B
Authority
HU
Hungary
Prior art keywords
ethyl
mmol
added
tert
nmr
Prior art date
Application number
HU87225A
Other languages
English (en)
Hungarian (hu)
Other versions
HUT45233A (en
Inventor
Shiro Terashima
Kunikazu Sakai
Yoshio Ito
Takeo Kawabata
Tamejiro Hiyama
Yoshikazu Kimura
Makoto Sunagawa
Katsumi Tamoto
Akira Sasaki
Original Assignee
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharma filed Critical Sumitomo Pharma
Publication of HUT45233A publication Critical patent/HUT45233A/hu
Publication of HU199428B publication Critical patent/HU199428B/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/38—One oxygen atom with acyl radicals or hetero atoms directly attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/26—Oxygen atoms attached in position 2 with hetero atoms or acyl radicals directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU87225A 1986-01-27 1987-01-26 Process for producing oxazolidine and imidazolidine compounds HU199428B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP1374786 1986-01-27
JP4606086 1986-03-05

Publications (2)

Publication Number Publication Date
HUT45233A HUT45233A (en) 1988-06-28
HU199428B true HU199428B (en) 1990-02-28

Family

ID=26349587

Family Applications (2)

Application Number Title Priority Date Filing Date
HU87225A HU199428B (en) 1986-01-27 1987-01-26 Process for producing oxazolidine and imidazolidine compounds
HU895128A HU209952B (en) 1986-01-27 1987-01-26 New process for producing optically active oxazolidine and imidazolidine derivatives

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU895128A HU209952B (en) 1986-01-27 1987-01-26 New process for producing optically active oxazolidine and imidazolidine derivatives

Country Status (9)

Country Link
EP (1) EP0232786B1 (enExample)
JP (1) JP2789190B2 (enExample)
KR (1) KR940008748B1 (enExample)
DE (1) DE3778049D1 (enExample)
ES (1) ES2039210T3 (enExample)
FI (1) FI92059C (enExample)
GR (1) GR3004335T3 (enExample)
HU (2) HU199428B (enExample)
IE (1) IE59138B1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5442055A (en) * 1992-11-13 1995-08-15 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US6011150A (en) * 1992-11-13 2000-01-04 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
US5631363A (en) * 1992-11-13 1997-05-20 Tanabe Seiyaku Co., Ltd. Azetidinone compound and process for preparation thereof
JP2856913B2 (ja) * 1993-05-18 1999-02-10 宣治 山下 可撓性型枠材及びそれを利用した貫通孔形成工法
US5550229A (en) * 1993-06-23 1996-08-27 Tanabe Seiyaku Co., Ltd. Alkylation process for preparing azetidinone compound and starting compound therefor
IT1391259B1 (it) * 2008-10-28 2011-12-01 Acs Dobfar Spa Derivati 1,3-imidazolidinici e loro utilizzo per la produzione di carbapenem
EP2345645A1 (en) 2009-12-22 2011-07-20 Savior Lifetec Corporation Method for manufacturing stereoselective preparation of 4-bma using a chiral auxiliary and chiral auxiliary
CN102250033A (zh) * 2011-05-27 2011-11-23 菏泽睿智科技开发有限公司 一种合成培南类抗生素的新型手性辅基的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422743A (de) * 1961-11-10 1966-10-31 Sandoz Ag Verfahren zur Herstellung neuer Phosphorsäureester
GB1482879A (en) * 1975-07-24 1977-08-17 Nippon Chemiphar Co 5-benzyl-2-oxazolidone derivatives and a process for producing the same
JPS6169839A (ja) * 1984-08-24 1986-04-10 Toray Ind Inc 着色エポキシ系球状微粒子
DK141786A (da) * 1985-03-29 1986-09-30 Merck & Co Inc Fremgangsmaade til fremstilling af et mellemprodukt til brug ved fremstilling af 1-beta-methylcarbapenemantibiotika
JPS61275267A (ja) * 1985-03-29 1986-12-05 メルク エンド カムパニ− インコ−ポレ−テツド 1−β−メチルカルバペネム抗生物質中間体の鏡像異性選択的製造方法

Also Published As

Publication number Publication date
JPS6310765A (ja) 1988-01-18
KR870007142A (ko) 1987-08-17
GR3004335T3 (enExample) 1993-03-31
DE3778049D1 (de) 1992-05-14
EP0232786A1 (en) 1987-08-19
FI870315L (fi) 1987-07-28
HUT45233A (en) 1988-06-28
FI92059B (fi) 1994-06-15
HU209952B (en) 1994-12-28
FI870315A0 (fi) 1987-01-26
FI92059C (fi) 1994-09-26
KR940008748B1 (ko) 1994-09-26
JP2789190B2 (ja) 1998-08-20
ES2039210T3 (es) 1993-09-16
IE59138B1 (en) 1994-01-12
IE870199L (en) 1987-07-27
HU895128D0 (en) 1990-03-28
EP0232786B1 (en) 1992-04-08

Similar Documents

Publication Publication Date Title
US5300638A (en) Asymmetric synthesis of taxol side chain
JPH0670006B2 (ja) ベータラクタム抗生物質中間体
HU194821B (en) Process for preparing optically active acyl-oxy-azetidinones
US4530793A (en) Processes for the production of penems
US20080090884A1 (en) Antimicrobial [3.1.0] bicyclohexylphenyl- oxazolidinone derivatives and analogues
EP0294934B1 (en) Diastereomeric 5R,6S-6-(1R-hydroxyethyl)-2-(cis-1-oxo-3-thiolanylthio)-2-penem-3-carboxylic acids
WO2009067960A2 (en) A method of manufacturing (3r,4s)-l-(4-fluorophenyl)-3-[(3s)-3-(4-fluorophenyl)-3- hydroxypropyl)]-4-(4-hydroxyphenyl)-2-azetidinone and its intermediates
EP0333268A1 (en) Process for synthesis of a chiral 3-beta hydrogen (3R) 4-aroyloxy azetidinone
US5231179A (en) Heterocyclic compounds and their production
EP0232786B1 (en) Heterocyclic compounds and their production
US4882429A (en) Stereospecific preparation of (3S,4R,5R)-3-(1-hydroxyethyl)-4-benzoyloxy-azeridinones from L-(-)-theonine
US4814442A (en) 6-hydroxyethyl-2-substituted thio-penem-3-carboxylates
KR100377448B1 (ko) 카바페넴 항생물질의 중간체 및 그의 제조방법
US4769451A (en) Synthesis of carbapenems using n-substituted azetidinones
JPS63188662A (ja) 新規なβ−ラクタム誘導体の製造方法
US4610820A (en) Process for the preparation of thienamycin and intermediates
EP0276993B1 (en) Process for preparing azetidinones
KR100385364B1 (ko) 카바페넴 항생물질의 중간체 및 그의 제조방법
US5134231A (en) 3(1-hydoxyethyl)azetidinone compounds and their production
JP3684339B2 (ja) カルバペネム化合物の製造方法
US4973687A (en) Synthesis of carbapenems using N-substituted azetidinones
JPS6332351B2 (enExample)
JPS62289558A (ja) β−ラクタム化合物およびその製造方法
JP2733256B2 (ja) 4−メルカプトピラゾリジン誘導体
US5145957A (en) Stereoselective synthesis of a chiral cis 3-beta hydrogen (3R) 4-aroyloxy azetidinone

Legal Events

Date Code Title Description
HU90 Patent valid on 900628
GB9A Succession in title

Owner name: DAINIPPON SUMITOMO PHARMA CO., LTD., JP

Free format text: FORMER OWNER(S): SUMITOMO PHARMACEUTICALS CO. LTD., JP

Owner name: JURIDICAL FOUNDATION SAGAMI CHEMICAL RESEARCH , JP

Free format text: FORMER OWNER(S): SUMITOMO PHARMACEUTICALS CO. LTD., JP